Outpatient Cardiac Telerehabilitation for Ischemic Heart Disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective interventional study compares standard outpatient cardiac rehabilitation with a hybrid telerehabilitation model in phase II for ischemic heart disease. The telerehabilitation uses remote education and exercise sessions, with in-person assessments and procedures at the hospital, plus smart wearables to monitor progress. The goal is to see if the hybrid approach can maintain safety and improve or maintain functional outcomes compared with usual care. Participants are adults with confirmed ischemic heart disease and adequate baseline exercise capacity. Exclusion criteria include implanted devices, language or cognitive barriers, significant comorbidities, and limited digital literacy.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Patients diagnosed with ischemic heart disease and referred to Phase II outpatient cardiac rehabilitation;
2. Adults aged 18 years and older;
3. Moderate to good functional exercise capacity, defined as a distance \> 225 meters on the Six-Minute Walk Test at baseline;
4. Willingness and ability to provide written informed consent to participate in the study.

Exclusion Criteria:

1. Presence of implanted cardiac devices;
2. Language barriers that may interfere with study participation;
3. Cognitive impairment, defined as a Mini-Mental State Examination score \< 25 points;
4. Comorbidities that may significantly affect the participant's ability to perform physical exercises, mobility, or activities of daily living, including musculoskeletal disorders, neurological diseases, or other relevant medical conditions;
5. Insufficient digital literacy or inability to use smart devices.

Where it's running

• Kulautuva Rehabilitation Hospital
  Kulautuva, Lithuania Recruiting

Study contacts

• Study coordinator: Emilija Laurecke
• Email: emilija.laurecke@stud.lsmu.lt
• Phone: +37064537135

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Tele-diabetes remote monitoring for kids with type 1 diabetes

  This study tests a tele-diabetes remote system that uses WhatsApp alerts to help children and teens manage their type 1 diabetes at home.

  Recruiting Sheba Medical Center · Ramat Gan · NCT07828106

• emPath platform pilot to link and keep adults with opioid use disorder in care in Durham

  This pilot tests a mobile app and telemedicine approach to help adults with opioid use disorder start and stay in MOUD through community outreach in Durham, NC.

  Recruiting Duke University · Durham, North Carolina · NCT07810322

• See if stopping long-term aspirin is as good as continuing it in older adults with stable ischemic heart disease

  In adults 65 and older with stable ischemic heart disease, this trial tests whether stopping daily low-dose aspirin is not worse than continuing it.

  Recruiting at 2 sites Phase 4 Odense University Hospital · Copenhagen and 1 other locations · NCT07795398

• Health Ahead: Comparing AI vs. Humans for Preventive Health Screening

  This study tests AI-assisted screening interpretation against human-only reads to see if automated screening can match or improve current practice for adults, especially in underserved areas.

  Recruiting Longevity Metrics, Inc. · Boulder, Colorado · NCT07669168

• QFR-guided virtual stenting to optimize PCI before the procedure

  We’re testing whether using QFR-based virtual stenting before PCI can improve heart-procedure outcomes compared with standard angiography planning in adults with coronary artery disease.

  Recruiting China National Center for Cardiovascular Diseases · Beijing, Beijing Municipality · NCT07635407

• LONG NAGOMI PMCF: follow-up of the Ultimaster Nagomi stent in long coronary artery lesions

  This project tests the Ultimaster Nagomi drug-eluting stent in adults undergoing PCI for long coronary lesions to collect real-world safety and effectiveness data.

  Recruiting at 10 sites Fundación EPIC · Cabueñes and 9 other locations · NCT07399002

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.